New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 2.380
-0.010 (-0.42%)
Feb 13, 2026, 3:04 PM CST
SHE:002219 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,100 | 3,789 | 3,903 | 3,153 | 3,007 | 2,794 |
Other Revenue | 9.78 | 9.78 | 11.19 | 8.13 | 8.79 | 12.13 |
| 3,110 | 3,799 | 3,914 | 3,161 | 3,016 | 2,806 | |
Revenue Growth (YoY) | -28.55% | -2.94% | 23.83% | 4.80% | 7.49% | -23.84% |
Cost of Revenue | 2,172 | 2,623 | 2,742 | 2,169 | 2,209 | 2,016 |
Gross Profit | 938.09 | 1,176 | 1,173 | 992.42 | 807.44 | 790.33 |
Selling, General & Admin | 639.06 | 805.16 | 874.74 | 690.55 | 717.15 | 557.05 |
Research & Development | 14.5 | 9.86 | 27.71 | 0.24 | 0.44 | 0.3 |
Other Operating Expenses | 28.27 | 22.44 | 21.17 | 17.92 | 20.38 | 13.94 |
Operating Expenses | 714.95 | 869.21 | 995.87 | 762.51 | 843 | 611.06 |
Operating Income | 223.14 | 307.21 | 176.87 | 229.91 | -35.56 | 179.27 |
Interest Expense | -131.01 | -135.03 | -128.48 | -142.62 | -230.03 | -136.61 |
Interest & Investment Income | 7.95 | 13.79 | 28.97 | 59.64 | 26.63 | 105.32 |
Currency Exchange Gain (Loss) | - | - | - | 0 | - | -0.3 |
Other Non Operating Income (Expenses) | -25.22 | -32.81 | -68.39 | 40.43 | -17.08 | -5.64 |
EBT Excluding Unusual Items | 74.86 | 153.16 | 8.97 | 187.36 | -256.03 | 142.03 |
Impairment of Goodwill | - | - | - | - | -102.59 | - |
Gain (Loss) on Sale of Investments | -0.49 | 0.01 | - | - | - | -0.19 |
Gain (Loss) on Sale of Assets | -0.48 | -0.07 | -0.19 | -0.17 | -0.67 | -4.84 |
Asset Writedown | -1.66 | -1.19 | -3.38 | -1.67 | -17.12 | -4.43 |
Legal Settlements | - | - | - | -0.39 | -0.3 | -3.79 |
Other Unusual Items | -3.66 | 2.33 | 5.69 | 2.47 | 14.33 | -118.79 |
Pretax Income | 68.58 | 154.23 | 11.09 | 187.59 | -362.39 | 9.99 |
Income Tax Expense | 51.76 | 33.9 | -28.77 | 22.71 | 4.91 | 52.5 |
Earnings From Continuing Operations | 16.82 | 120.33 | 39.86 | 164.89 | -367.3 | -42.51 |
Minority Interest in Earnings | 2.76 | -5.56 | -10.89 | -8.77 | -4.13 | -9.73 |
Net Income | 19.58 | 114.77 | 28.97 | 156.12 | -371.43 | -52.24 |
Net Income to Common | 19.58 | 114.77 | 28.97 | 156.12 | -371.43 | -52.24 |
Net Income Growth | -62.54% | 296.13% | -81.44% | - | - | - |
Shares Outstanding (Basic) | 3,257 | 3,288 | 3,255 | 3,266 | 1,866 | 1,866 |
Shares Outstanding (Diluted) | 3,257 | 3,288 | 3,255 | 3,266 | 1,866 | 1,866 |
Shares Change (YoY) | -1.65% | 1.02% | -0.33% | 75.08% | -0.02% | -0.03% |
EPS (Basic) | 0.01 | 0.03 | 0.01 | 0.05 | -0.20 | -0.03 |
EPS (Diluted) | 0.01 | 0.03 | 0.01 | 0.05 | -0.20 | -0.03 |
EPS Growth | -61.91% | 292.13% | -81.38% | - | - | - |
Free Cash Flow | 91.95 | 131.06 | 111.25 | 46.47 | 78.56 | 67.23 |
Free Cash Flow Per Share | 0.03 | 0.04 | 0.03 | 0.01 | 0.04 | 0.04 |
Gross Margin | 30.17% | 30.97% | 29.96% | 31.40% | 26.77% | 28.17% |
Operating Margin | 7.17% | 8.09% | 4.52% | 7.27% | -1.18% | 6.39% |
Profit Margin | 0.63% | 3.02% | 0.74% | 4.94% | -12.31% | -1.86% |
Free Cash Flow Margin | 2.96% | 3.45% | 2.84% | 1.47% | 2.60% | 2.40% |
EBITDA | 346.8 | 466.94 | 384.69 | 385.85 | 127.28 | 349.92 |
EBITDA Margin | 11.15% | 12.29% | 9.83% | 12.21% | 4.22% | 12.47% |
D&A For EBITDA | 123.66 | 159.73 | 207.82 | 155.94 | 162.84 | 170.65 |
EBIT | 223.14 | 307.21 | 176.87 | 229.91 | -35.56 | 179.27 |
EBIT Margin | 7.17% | 8.09% | 4.52% | 7.27% | -1.18% | 6.39% |
Effective Tax Rate | 75.48% | 21.98% | - | 12.10% | - | 525.52% |
Revenue as Reported | 3,110 | 3,799 | 3,914 | 3,161 | 3,016 | 2,806 |
Advertising Expenses | - | 265.25 | 187.86 | 71.92 | 58.15 | 51.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.